From: IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center
Late toxicity | Grade 2% (n) | Grade 3% (n) | Grade 4% (n) |
---|---|---|---|
Skin | 3 (1) | 0 | 0 |
Gastrointestinal | 25 (7) | 7 (2) | 0 |
Genitourinary | 14 (4) | 0 | 0 |
Bone | 3 (1) | 0 | 0 |
Vaginal | 28,5 (6) | 5 (1) | 0 |
Hematologic * | 0 | 0 | 0 |